Cardiac drug safety a bench to bedside approach
Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Language: | English |
Published: |
New Jersey
World Scientific Publishing
2012
|
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Challenges facing the pharmaceutical industry in the 21st century
- The cellular basis of cardiac electrophysiology
- Clinical arrhythmia syndromes
- The mechanisms underlying cardiac arrhythmias
- The mechanisms underlying drug-induced arrhythmias
- Assessing cardiac safety in drug development
- Pediatric cardiac safety
- Drug-induced atrial fibrillation
- Navigating the future path of cardiac drug safety.